1. Market Research
  2. > Biotechnology
  3. > Biopharmaceutical Market Trends
  4. > 2014 Sales of Recombinant Therapeutic Antibodies & Proteins

2014 Sales of Recombinant Therapeutic Antibodies & Proteins

  • March 2015
  • -
  • La Merie Publishing
  • -
  • 39 pages

2014 Sales of Recombinant Therapeutic Antibodies & Proteins


This Competitive Intelligence report prepared by La Merie Business Intelligence provides a compilation of the sales data of recombinant therapeutic proteins and antibodies in the calendar year 2014. Sales data were obtained from company publications and refer to branded products originating from companies based in regulated markets. All sales data were converted from their original, published currency into US$ using official currency exchange rates as of March 17, 2015. Sales figures represent the sum of revenues in all territories where the products are marketed and are mostly presented either after hedging.


Sales data are presented for each product within the respective class of biologics. The data were analyzed to establish a ranking list of blockbuster biologics with 2014 sales higher than US$ 1 bln. Another ranking list was prepared for companies according to biologics sales in 2014 and the percentage of antibody sales vs protein sales.


 


Table Of Contents

2014 Sales of Recombinant Therapeutic Antibodies and Proteins

2014 Sales of Recombinant Therapeutic Antibodies andamp; Proteins


Table of Contents:


2014 Biologics Sales per Class of Products

Blockbuster Biologics in 2014 (by generic name)

Company Ranking List for Biologics Sales 2014

Biologic Product Sales 2014

•          Anti-TNF Antibodies

•          Cancer Antibodies

•          Insulin and Insulin Analogs

•          Anti-Inflammatory and Anti-Autoimmune Antibodies

•          Recombinant Coagulation Factors

•          Ophthalmic Antibodies

•          Erythropoietins

•          Interferon beta

•          G-CSF

•          Enzyme Replacement Proteins

•          Human Growth Hormone

•          Interferon alpha

•          Follicle Stimulating Hormone

•          Cardiometabolic andamp; Anti-Infective Antibodies

•          Other Proteins: Cardiometabolic, Cancer andamp; Others


View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Global Laboratory Products Purchasing Trends, 2016–2017

Global Laboratory Products Purchasing Trends, 2016–2017

  • $ 6000
  • Industry report
  • December 2016
  • by Frost & Sullivan

An End-user Perspective on the Purchasing Process, Product Budgets, and Top Companies for Laboratory Products Readers of Lab Manager Magazine were invited to participate in an online survey in July 2016. ...

Biosimilars Market by Product, Manufacturing, Application - Global Forecast to 2021

Biosimilars Market by Product, Manufacturing, Application - Global Forecast to 2021

  • $ 5650
  • Industry report
  • January 2017
  • by MarketsandMarkets

Biosimilars Market by Product (Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon), glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin)), Manufacturing (In-House, CM0) & Application ...

PEGylated Proteins Market by Consumables, Services, Protein Type, Application, End-User - Global Forecast to 2021

PEGylated Proteins Market by Consumables, Services, Protein Type, Application, End-User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • November 2016
  • by MarketsandMarkets

The global PEGylated proteins market is expected to USD 1,137.8 million by 2021 from USD 690.6 million in 2016, at a CAGR of 10.5% between 2016 and 2021. The growth of this market is mainly driven by increase ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.